News - Eliquis, Galvus

Filter

Current filters:

EliquisGalvus

Popular Filters

1 to 25 of 46 results

Pfizer revenues down as patent losses hit sales

Pfizer revenues down as patent losses hit sales

29-10-2013

Global pharma giant Pfizer has said worldwide sales fell 2% to $12.6 billion, hurt by generic competition,…

AriceptEliquisEnbrelFinancialLipitorNorth AmericaPfizerPharmaceuticalRebifSpiriva

Bayer/Janssen's Xarelto poised to lead sales in VTE market: report

30-08-2013

German drug major Bayer (BAYN: DE) and Johnson & Johnson (NYSE: JNJ) subsidiary Janssen's Xarelto (rivaroxaban)…

BayerBristol-Myers SquibbCardio-vascularEliquisGlobalJanssenJohnson & JohnsonMarkets & MarketingPfizerPharmaceuticalXarelto

US FDA accepts Bristol-Myers/Pfizer' Eliquis sNDA

12-07-2013

US pharma major Bristol-Myers Squibb (NYSE: BMY) and behemoth Pfizer (NYSE: PFE) announced that the US…

Bristol-Myers SquibbCardio-vascularEliquisNorth AmericaPfizerPharmaceuticalRegulation

Positive new data on Novartis' Galvus in elderly type 2 diabetes patients

23-05-2013

Results of the INTERVAL study were published on line in The Lancet today (May 23) and for the first time…

DiabetesGalvusNovartisPharmaceuticalResearch

Positive results from sub-analysis of Eliquis ARISTOTLE trial

07-05-2013

US drug major Bristol-Myers Squibb (NYSE: BMY) and partner Pfizer (NYSE: PFE) reported results from a…

Bristol-Myers SquibbCardio-vascularEliquisPfizerPharmaceuticalResearch

Germany's IQWiG finds considerable added benefit for Bristol-Myers/Pfizer's Eliquis

05-04-2013

In an early benefit assessment under the German Act on the Reform of the Market for Medicinal Products…

Bristol-Myers SquibbCardio-vascularEliquisEuropePfizerPharmaceuticalPricingRegulation

Xarelto and Eliquis set to displace current therapies in DVT/PE

28-03-2013

Clinical data and the opinions of interviewed thought leaders indicate that there is little to distinguish…

BayerBristol-Myers SquibbCardio-vascularEliquisEuropeJohnson & JohnsonMarkets & MarketingNorth AmericaPfizerPharmaceuticalXarelto

US FDA finally approves Bristol-Myers/Pfizer's Eliquis for stroke prevention in AF patients

31-12-2012

The US Food and Drug Administration on December 28 finally approved the anti-clotting drug Eliquis (apixaban),…

Bristol-Myers SquibbCardio-vascularEliquisNorth AmericaPfizerPharmaceuticalRegulation

Bristol-Myers and Pfizer's Eliquis sees first European launch, in the UK

14-12-2012

US drug major Bristol-Myers Squibb (NYSE: BMY) and partner global pharma behemoth Pfizer (NYSE: PFE)…

Bristol-Myers SquibbCardio-vascularEliquisEuropeMarkets & MarketingPfizerPharmaceutical

Bristol-Myers/Pfizer's Eliquis gets EU backing for stroke prevention and NVAF

22-11-2012

US drug major Bristol-Myers Squibb (NYSE: BMY) and partner Pfizer (NYSE: PFE), the world's largest drugmaker…

Bristol-Myers SquibbCardio-vascularEliquisEuropePfizerPharmaceuticalRegulation

FDA sets March 2013 PDUFA date for re-submitted Eliquis

28-09-2012

The US Food and Drug Administration has acknowledged receipt of the New Drug Application resubmission…

Bristol-Myers SquibbCardio-vascularEliquisNorth AmericaPfizerPharmaceuticalRegulation

1 to 25 of 46 results

Back to top